HOXB13表达与前列腺癌根治术后转移进展相关
基于两个回顾性前列腺切除术队列(Mayo Clinic n=780;JHMI n=355)和一个前瞻性基因组登记(n=5239),分析HOXB13 mRNA表达与术后无转移生存的关系。结果显示HOXB13最高四分位与较低四分位相比无转移生存更差,且HOXB13高表达合并MEIS1/2低表达时风险进一步升高。
要点
- HOXB13高表达与根治术后无转移生存更差相关。
- HOXB13高表达合并MEIS1或MEIS2低表达者转移风险更高。
- 该表型可能提示对雄激素抑制更敏感。
核心结论
- 原发前列腺癌HOXB13表达升高者根治术后转移倾向增加,尤其合并MEIS1/2低表达时。
研究设计与样本
- 回顾性分析两个前列腺切除术队列(Mayo Clinic n=780;JHMI n=355)及一个前瞻性基因组登记(n=5239)。
- 采用多变量Cox回归分析无转移生存(MFS)。
主要发现
- HOXB13表达随肿瘤分级升高而增加,并与基因组特征提示的高转移潜能相关。
- HOXB13最高四分位与最低四分位相比MFS更差:Mayo Clinic调整风险比(AHR)1.46,95%CI 1.03-2.06;JHMI AHR 1.80,95%CI 1.02-3.19。
- HOXB13高表达合并MEIS1低表达AHR 2.03(95%CI 1.54-2.66),合并MEIS2低表达AHR 1.73(95%CI 1.33-2.26),均提示MFS更差。
- HOXB13高表达合并MEIS1/2低表达与雄激素受体介导基因高表达相关。
临床怎么用
- HOXB13高表达尤其合并MEIS1/2低表达的前列腺癌术后患者可能需更密切监测转移。
- 该分子特征提示对雄激素抑制可能更敏感,但需进一步验证。
局限性
- 研究为回顾性设计,未测量变量可能导致偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Homeobox B13 (HOXB13) expression regulates normal prostate development and mutations are associated with prostate cancer (PCa) formation. OBJECTIVE: To assess the role of HOXB13 mRNA expression in PCa progression following radical prostatectomy. DESIGN, SETTING, AND PARTICIPANTS: Genome-wide expression profiles were queried from two retrospective prostatectomy cohorts with follow-up data (Mayo Clinic, n=780; Johns Hopkins Medical Institute [JHMI], n=355), and a prospective genomic registry (n=5239). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable Cox regressions were used to analyze metastasis-free survival (MFS). RESULTS AND LIMITATIONS: HOXB13 expression in primary PCa increased with increasing tumor grade and with high metastatic potential based on a genomic signature. The highest quartile of HOXB13 expression was associated with worse MFS compared with the lowest quartile (Mayo Clinic: adjusted hazard ratio [AHR] 1.46, 95% confidence interval [CI] 1.03-2.06, and JHMI: AHR 1.80, 95% CI 1.02-3.19). The combinations of high HOXB13 expression and low expression of its binding partner, MEIS1 (AHR 2.03, 95% CI 1.54-2.66) or MEIS2 (AHR 1.73, 95% CI 1.33-2.26), portended worse MFS. Additionally, high HOXB13 expression in combination with low MEIS1/2 expression correlated with high expression of androgen receptor-mediated genes. The retrospective nature of this study subjects the findings to a bias due to unmeasured variables. CONCLUSIONS: Primary PCa tumors with increased HOXB13 expression have an increased propensity for metastases following prostatectomy, particularly in the setting of low MEIS1/2 expression. High androgen receptor output may account for worse outcomes for these tumors and suggests heightened sensitivity to androgen suppression. PATIENT SUMMARY: Using genomic data from a large number of prostate cancer (PCa) tumors, we found that increased expression of homeobox B13 (HOXB13), a gene related to normal prostate development, was associated with worse outcomes following surgery for PCa. A biomarker signature suggests that these tumors would be more susceptible to androgen suppression, a common treatment for PCa. Take Home Messagece:: In multiple large cohorts, prostate cancer tumors with high homeobox B13 (HOXB13) expression and low expression of its binding partner MEIS1/2 were enriched with high androgen receptor output and had an increased propensity for metastases following surgery.
引用
- Weiner AB, Faisal FA, Davicioni E, et al. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy. Eur Urol Oncol. 2020. PMID: 32540218. doi:10.1016/j.euo.2020.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。